Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230

Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T. J. Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Mottaghy, Agnieszka Morgenroth^*

^*Corresponding author for this work

DA BV Radiochemicus Chemisch Analist
NUTRIM - Obesity, diabetes and cardiovascular health
Beeldvorming

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

1 Article

1 results

Filter

2022

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
Sankaranarayanan, R. A., Peil, J., Vogg, A. T. J., Bolm, C., Terhorst, S., Classen, A., Bauwens, M., Maurer, J., Mottaghy, F. & Morgenroth, A., 1 Jan 2022, In: Cancers. 14, 1, 18 p., 230.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230

Research output

Search results

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study